t, J = 7.0 Hz, 2CH3), 1.43 (6H, t, J = 7.0 Hz, 2CH3), 2.43 (6H, s,
2CH3), 4.29 (4H, q, J = 7.0 Hz, 2CH2), 4.47 (4H, q, J = 7.3 Hz,
2CH2), 7.84 (2H, s, 2CH). 13C NMR δC (CDCl3, 75 MHz): 14.0,
(2CH3-triaz.), 14.3, (2CH3-thiadiaz.), 20.1, (2 CH3), 62.4,
(2OCH2-triaz.), 62.7, (2OCH2-thiadiaz.), 128.2, (2CH-arom.),
129.1, (2NC-arom.), 134.4, (C5-triaz.), 141.3, (C4-triaz.), 142.3,
(2CH3C-arom.), 147.1, (C4-thiadiaz.), 158.9, (CO-triaz.), 160.2,
(C5-thiadiaz.), 160.7 (CO-thiadiaz.). ESI-MS 761 (MHϩ).
EIMS m/z (rel. int.): 514(1), 486(6), 414(15), 314(15), 286(54),
242(59), 214(100), 157(23). Anal. Calcd for C28H28N10O8S4: C,
44.20; H, 3.71; N, 18.41; S, 16.86. Found C, 44.16; H, 3.73; N,
18.35; S, 16.97%.
221(38), 139(55), 116(54), 85(86), 68(67). Anal. Calcd for
C18H22N8O6S3: C, 39.84; H, 4.09; N, 20.65. Found C, 39.92; H,
4.01; N, 20.49%.
Diethyl
9,10-dihydrobis[1,2,3]triazolo[1,5-f:5Ј,1Ј-b][1,3,6]-
thiadiazepine-3,5-dicarboxylate 7a. A suspension of 5a (1.0 g,
1.46 mmol) in ethanol (20 mL) with triethylamine (0.6 mL,
4.3 mmol) was refluxed and enough DMF was added to
dissolve all the starting material. After 2 days of refluxing the
reaction mixture was diluted with water (60 mL) and extracted
with dichloromethane (3 × 20 mL). Evaporation of the solvent
gave a crude product which was crystallized from ethanol
to give 0.45 g (91%) of thiadiazepine 7a, mp 192 ЊC. 1H
NMR δH (CDCl3, 400 MHz): 1.45 (6H, t, J = 7.1 Hz, 2CH3),
4.47 (4H, q, J = 7.1 Hz, 2OCH2), 5.12 (4H, s, CH2CH2). 13C
NMR δC (CDCl3, 100 MHz): 14.21 (qt, J = 127.5, 2.6 Hz,
2CH3), 49.33 (tt, J = 146.6, 3.7 Hz, CH2CH2), 61.99 (tq,
J = 148.7, 4.5 Hz, 2OCH2), 130.20 (tt, J = 1.5, 1.5 Hz,
C5-triaz.), 138.04 (s, C4-triaz.), 159.89 (t, J = 3.4 Hz, CO).
EIMS m/z (rel. int.): 338 (Mϩ, 100). Anal. Calcd for
C12H14N6O4S: C, 42.60; H, 4.17; N, 24.84; S, 9.48. Found
C, 42.53; H, 4.20; N, 24.91; S, 5.60%. When the ethanol
filtrate combined with the water layer from extraction was acid-
ified with HCl, the precipitated product (0.20 g) was character-
ized as bis(4-ethoxycarbonyl-1,2,3-thiadiazol-5-yl)disulfide 9.
The spectroscopic and analytical data of this product were
identical to those reported earlier.1
5,5Ј-{4-Methyl-1,2-phenylenebis[(4-methyl-1H-1,2,3-triazole-
1,5-diyl)sulfanyl]}bis(4-methyl-1,2,3-thiadiazole) 5m. Prepared
1
from 1a and 2m as described for 5j. Yield 76%, mp 190 ЊC. H
NMR δH (CDCl3, 400 MHz): 1.32 (6H, t, J = 7.2 Hz, 2CH3-
triaz.), 1.470 (3H, t, J = 7.1 Hz, CH3-thiadiaz.), 1.474 (3H, t,
J = 7.1 Hz, CH3-thiadiaz.), 2.55 (3H, dd, J = 0.9, 0.8 Hz, CH3),
4.386 (2H, q, J = 7.2 Hz, OCH2-triaz.), 4.388 (2H, q, J = 7.2 Hz,
OCH2-triaz.), 4.52 (2H, q, J = 7.2 Hz, OCH2-thiadiaz.), 4.53
(2H, q, J = 7.2 Hz, OCH2-thiadiaz.), 7.34 (1H, dq, J = 1.8,
0.9 Hz, C3H), 7.42 (1H, d, J = 8.2 Hz, C6H), 7.60 (1H, ddq,
J = 8.2, 1.8, 0.8 Hz, C5H). 13C NMR δC (CDCl3, 100 MHz):
13.95 (qt, J = 127.5, 2.6 Hz, 2CH3-triaz.), 14.20 (qt, J = 127.5,
2.6 Hz, 2CH3-thiadiaz.), 21.48 (qt, J = 128.4, 4.1 Hz, CH3),
62.32 (tq, J = 148.9, 4.4 Hz, 2OCH2-triaz.), 62.66 (tq, J = 148.7,
4.3 Hz, OCH2-thiadiaz.), 62.67 (tq, J = 148.9, 4.4 Hz, OCH2-
thiadiaz.), 128.19 (d, J = 167.6 Hz, C6-arom.), 128.24 (d,
J = 8.0 Hz, C2-arom.), 129.10 (dddd, J = 164.3, 6.7, 5.5, 1.1 Hz,
C3-arom.), 130.51 (dt, J = 8.7, 1.8 Hz, C1-arom.), 132.95
(dddq, J = 163.9, 9.0, 3.4, 1.8 Hz, C5-arom.), 134.26 (s,
C5-triaz.), 134.39 (s, C5-triaz.), 141.30 (s, C4-triaz.), 141.43
(s, C4-triaz.), 143.75 (dq, J = 8.2, 5.9 Hz, C4-arom.), 147.05 (s,
C4-thiadiaz.), 147.17 (s, C4-thiadiaz.), 158.81 (t, J = 3.2 Hz,
CO-triaz.), 159.86 (s, C5-thiadiaz.), 160.01 (s, C5-thiadiaz.),
160.62 (t, J = 3.4 Hz, CO-thiadiaz.), 160.64 (t, J = 3.4 Hz,
CO-thiadiaz.). ESI-MS 747 (MHϩ). EIMS m/z (rel. int.):
472(15), 400(9), 300(13), 272(46), 228(67), 200(100), 116(36),
89(57). Anal. Calcd for C27H26N10O8S4: C, 43.42; H, 3.51;
N, 18.75; S, 17.17. Found C, 43.38; H, 3.59; N, 18.55; S,
17.00%.
Diethyl 9-methyl-9,10-dihydrobis[1,2,3]triazolo[1,5-f:5Ј,1Ј-b]-
[1,3,6]thiadiazepine-3,5-dicarboxylate 7b. Prepared from 5b as
described for 7a. Yield 73%, mp 168 ЊC. 1H NMR δH (DMSO-
D6, 400 MHz): 1.33–1.37 (9H, m, 3CH3), 4.38 (2H, q, J = 7.1
Hz, CH2), 4.39 (2H, q, J = 7.1 Hz, CH2), 5.16, 5.27 (2H,
AB-syst., J = 15.1, 5.5, 1.1 Hz, CH2), 5.59 (1H, m, CH). 13C
NMR δC (CDCl3, 75 MHz): 14.3 (CH2CH3), 14.3 (CH2CH3),
17.8 (CH3), 53.0 (CH), 56.2 (CH2), 62.0 (OCH2), 62.1 (OCH2),
129.4, 130.6, 137.4, 138.5, 159.8 (CO), 160.2 (CO). EIMS m/z
(rel. int.): 352 (Mϩ, 100). Anal. Calcd for C13H16N6O4S: C,
44.31; H, 4.58; N, 23.85; S, 9.10. Found C, 44.38; H, 4.54; N,
23.97; S, 9.31%.
Diethyl
6,7-dihydro-5H-bis[1,2,3]triazolo[1,5-g:5Ј,1Ј-b]-
[1,3,7]thiadiazocine-1,11-dicarboxylate 7c. Prepared from 5c as
described for 7a. Yield 79%, mp 203 ЊC. 1H NMR δH (DMSO-
D6 ϩ CCl4, 250 MHz): 1.41 (6H, t, J = 7.0 Hz, 2CH3), 2.19 (2H,
m, CH2CH2CH2), 4.28–4.48 (8H, m, 2OCH2 ϩ CH2CH2CH2).
13C NMR δC (CDCl3, 75 MHz): 14.3 (2CH3), 27.7
(CH2CH2CH2), 44.9 (2NCH2), 62.1 (2OCH2), 131.3, 138.5,
160.2 (2CO). EIMS m/z (rel. int.): 352 (Mϩ, 100). Anal. Calcd
for C13H16N6O4S: C, 44.31; H, 4.58; N, 23.85. Found C, 44.29;
H, 4.61; N, 23.80%.
Ethyl 5-[(1-methyl-2-{4-ethoxycarbonyl-5-[(4-ethoxycarbonyl-
1,2,3-thiadiazol-5-yl)sulfanyl]-1H-1,2,3-triazol-1-yl}ethyl)-
amino]-1,2,3-thiadiazole-4-carboxylate 6. A solution of bromo-
ester 1a (0.5 g, 2.1 mmol) and 0.75 equivalents of 1,2-
propylenediamine 2b (0.12 g) in chloroform (5 mL) was refluxed
for 3 hours. After removal of the solvent, the residue was dis-
solved in ethanol and kept for two days, The product slowly
precipitated and was filtered off yielding 0.046 g (12%) of 6, mp
178 ЊC. 1H NMR δH (CDCl3, 400 MHz): 1.33 (3H, t, J = 7.2 Hz,
CH3-triaz.), 1.44 (3H, t, J = 7.2 Hz, CH3-thiadiaz.NH), 1.48
(3H, d, J = 6.5 Hz, CH3), 1.52 (3H, t, J = 7.2 Hz, CH3-
thiadiaz.), 3.87 (1H, dqt, J = 8.9, 6.5, 6.2 Hz, CH), 4.38 (2H, q,
J = 7.1 Hz, OCH2-triaz.), 4.42 (2H, qd, J = 7.1, 1.8 Hz, OCH2-
thiadiaz.NH), 4.58 (2H, q, J = 7.2 Hz, OCH2-thiadiaz.), 4.70
(1H, d, J = 6.2 Hz, CH2), 7.85 (1H, d, J = 8.9 Hz, NH). 13C
NMR δC (CDCl3, 100 MHz): 14.06 (qt, J = 127.5, 2.6 Hz, CH3-
triaz.), 14.33 (qt, J = 127.3, 2.6 Hz, CH3-thiadiaz.NH ϩ CH3-
thiadiaz.), 18.57 (qd, J = 128.8, 2.9 Hz, CH3), 52.60 (t, J = 143.2
Hz, CH2), 58.65 (d, J = 139.7 Hz, CH), 61.74 (tq, J = 148.2, 4.5
Hz, OCH2-thiadiaz.NH), 62.32 (tq, J = 148.7, 4.3 Hz, OCH2-
triaz.), 62.93 (tq, J = 149.1, 4.5 Hz, OCH2-thiadiaz.), 132.15 (t,
J = 2.5 Hz, C5-triaz.), 132.43 (d, J = 1.5 Hz, C4-thiadiaz.NH),
141.72 (s, C4-triaz.), 147.14 (s, C4-thiadiaz.), 159.15 (t, J = 3.2
Hz, CO-triaz.), 159.87 (s, C5-thiadiaz.), 160.61 (t, J = 3.4 Hz,
CO-thiadiaz.), 163.50 (t, J = 3.2 Hz, CO-thiadiaz.NH), 169.63
(dd, J = 3.8, 2.3 Hz, C5-thiadiaz.NH). ESI-MS 543 (MHϩ).
EIMS m/z (rel. int.): 514(3), 384(3), 352(68), 307(12), 235(100),
2-Ethoxy-8,10-bis(ethoxycarbonyl)di[1,2,3]triazolo[1,5-a;5Ј,
1Ј-d][3,1,5]benzothiadiazepine 7j. To a solution of 1a (1.0 g,
4.22 mmol) and 4-ethoxy-1,2-phenylenediamine 2j (0.33 g 2.1
mmol) in ethanol (80 mL), triethylamine (0.6 mL, 4.2 mmol)
was added and the reaction mixture was refluxed overnight.
Then a second portion of triethylamine (1.2 mL) was added
and soon the product precipitated from the boiling solution.
After refluxing for an additional hour, the reaction mixture
was cooled, and the product was filtered off and crystallized
from ethanol yielding 0.38 g (42%) of thiadiazepine 7j, mp
168 ЊC. 1H NMR δH (DMSO-D6 ϩ CCl4, 250 MHz): 1.42 (3H,
t, J = 7.0 Hz, CH2), 1.43 (3H, t, J = 7.0 Hz, CH3), 1.47 (3H, t,
J = 7.0 Hz, CH3ethoxy), 4.26 (2H, q, J = 7.0 Hz, OCH2ethoxy),
4.40 (2H, q, J = 7.0 Hz, OCH2), 4.41 (2H, q, J = 7.0 Hz, OCH2),
7.41 (1H, dd, J = 9.2, 2.7 Hz, C3H), 7.52 (1H, d, J = 2.7 Hz,
C1H), 7.99 (1H, d, J = 9.2 Hz, C4H). EIMS m/z (rel. int.): 430
(Mϩ, 18). Anal. Calcd for C18H18N6O5S: C, 50.23; H, 4.22; N,
19.52; S, 7.45. Found C, 50.31; H, 4.20; N, 19.70; S, 7.20%.
O r g . B i o m o l . C h e m . , 2 0 0 3 , 1, 4 0 3 0 – 4 0 3 8
4037